0001694665-22-000134.txt : 20221014 0001694665-22-000134.hdr.sgml : 20221014 20221014163241 ACCESSION NUMBER: 0001694665-22-000134 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220719 FILED AS OF DATE: 20221014 DATE AS OF CHANGE: 20221014 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zung Jonathan B. CENTRAL INDEX KEY: 0001837972 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38473 FILM NUMBER: 221311662 MAIL ADDRESS: STREET 1: C/O EVELO BIOSCIENCES, INC. STREET 2: 620 MEMORIAL DRIVE, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evelo Biosciences, Inc. CENTRAL INDEX KEY: 0001694665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465594527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 620 MEMORIAL DRIVE SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-577-0300 MAIL ADDRESS: STREET 1: 620 MEMORIAL DRIVE SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wf-form4_166577953055922.xml FORM 4 X0306 4 2022-07-19 0 0001694665 Evelo Biosciences, Inc. EVLO 0001837972 Zung Jonathan B. C/O EVELO BIOSCIENCES, INC. 620 MEMORIAL DRIVE CAMBRIDGE MA 02139 0 1 0 0 Chief Development Officer Stock Option (Right to Buy) 2.24 2022-07-19 4 A 0 115000 0 A 2032-07-19 Common Stock 115000.0 115000 D The option will vest as to 50% of the underlying shares on the first anniversary of the date of grant, and as to the remaining 50% of the underlying shares on the second anniversary of the date of grant. /s/ Daniel S. Char, Attorney-in-Fact for Jonathan B. Zung 2022-10-14